GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FNLC · Sep 30, 2025

First Bancorp, Inc /ME/. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000765207-25-000055Bank
Sequential deposit growth40thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.19% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

19.96% · CORE · VALID

Interest-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

7.10% · CORE · VALID

Cash and equivalents90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$31.6M · CORE · VALID

Sequential loan growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.18% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History62 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-0.22%
Current
1.19%
Delta
1.41%
Earnings Growth Decreased
Previous
30.66%
Current
19.96%
Delta
-10.70%
Interest Income Growth Decreased
Previous
8.94%
Current
7.10%
Delta
-1.84%
Liquidity Increased
Previous
$27.4M
Current
$31.6M
Delta
$4.2M
Loan Growth Decreased
Previous
0.47%
Current
0.18%
Delta
-0.29%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.